Skip to main content

Table 2 Baseline characteristics of AS patients and healthy controls

From: Dysregulation of ribosome-related genes in ankylosing spondylitis: a systems biology approach and experimental method

Property AS patients (n = 20) Healthy controls (n = 20)
Male/ Female 15/5 (75%/25%) 15/5 (75%/25%)
Age 35 ± 11.3 36 ± 7.4
BASDAI 6.4 ± 2
BASFI 4.5 ± 2.6
BASMI 3.2 ± 1.2
Disease duration 8.7 ± 9.8
HLA-B27 positive 80% 0
ESR 29.3 ± 25.2
ASQol 9.6 ± 4.8
  1. AS ankylosing spondylitis, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Functional Index, BASMI Bath Ankylosing Spondylitis Metrology Index, HLA-B27 Human Leukocyte Antigen (subtypes B*2701–2759), ESR Erythrocyte Sedimentation Rate, ASQol Ankylosing Spondylitis Quality of Life